{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:26:20Z","timestamp":1794119180018,"version":"4.8.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK81872 NIH"],"award-info":[{"award-number":["R01 DK81872 NIH"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-017-1498-3","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T13:06:42Z","timestamp":1515676002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Chi Chiu","family":"Mok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling Yin","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faten Ismail","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"1498_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jcp.56.7.481","volume":"56","author":"CC Mok","year":"2003","unstructured":"Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56:481\u201390.","journal-title":"J Clin Pathol"},{"key":"1498_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrrheum.2015.174","volume":"12","author":"CC Mok","year":"2016","unstructured":"Mok CC. Towards new avenues in the management of lupus glomerulonephritis. Nat Rev Rheumatol. 2016;12:221\u201334.","journal-title":"Nat Rev Rheumatol"},{"key":"1498_CR3","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/art.38006","volume":"65","author":"CC Mok","year":"2013","unstructured":"Mok CC, Kwok RC, Yip PS. Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus. Arthritis Rheum. 2013;65:2154\u201360.","journal-title":"Arthritis Rheum"},{"key":"1498_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/096120339500400206","volume":"4","author":"JV Donadio Jr","year":"1995","unstructured":"Donadio Jr JV, Hart GM, Bergstralh EJ, Holley KE. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus. 1995;4:109\u201315.","journal-title":"Lupus"},{"key":"1498_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0272-6386(99)70361-6","volume":"34","author":"CC Mok","year":"1999","unstructured":"Mok CC, Wong RW, Lau CS. Lupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcome. Am J Kidney Dis. 1999;34:315\u201323.","journal-title":"Am J Kidney Dis"},{"key":"1498_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/0961203317717082","volume":"27","author":"M Jolly","year":"2018","unstructured":"Jolly M, Toloza S, Goker B, Rourre-Tessier G, Clark A, Navarra S, et al. Disease specific quality of life in patients with lupus nephritis. Lupus. 2018;27:257\u201364.","journal-title":"Lupus."},{"key":"1498_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1177\/0961203308094280","volume":"17","author":"CC Mok","year":"2008","unstructured":"Mok CC, Cheung MY, Ho LY, Yu KL, To CH. Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus. Lupus. 2008;17:1103\u20137.","journal-title":"Lupus"},{"key":"1498_CR8","doi-asserted-by":"publisher","first-page":"638413","DOI":"10.1155\/2010\/638413","volume":"2010","author":"CC Mok","year":"2010","unstructured":"Mok CC. Biomarkers for lupus nephritis: a critical appraisal. J Biomed Biotechnol. 2010;2010:638413.","journal-title":"J Biomed Biotechnol"},{"key":"1498_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2217\/bmm.15.25","volume":"9","author":"B Goilav","year":"2015","unstructured":"Goilav B, Putterman C, Rubinstein TB. Biomarkers for kidney involvement in pediatric lupus. Biomark Med. 2015;9:529\u201343.","journal-title":"Biomark Med"},{"key":"1498_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12016-010-8197-z","volume":"40","author":"J Reyes-Thomas","year":"2011","unstructured":"Reyes-Thomas J, Blanco I, Putterman C. Urinary biomarkers in lupus nephritis. Clin Rev Allergy Immunol. 2011;40:138\u201350.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1498_CR11","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1074\/mcp.M112.021667","volume":"12","author":"T Wu","year":"2013","unstructured":"Wu T, Du Y, Han J, Singh S, Xie C, Guo Y, et al. Urinary angiostatin\u2013a novel putative marker of renal pathology chronicity in lupus nephritis. Mol Cell Proteomics. 2013;12:1170\u20139.","journal-title":"Mol Cell Proteomics"},{"key":"1498_CR12","unstructured":"Stanley S, Ding H, Pedroza C, Saxena R, Petri M, Mohan C. Comprehensive Aptamer-based screening of 1129 proteins reveals novel urinary biomarkers of lupus nephritis. [abstract] Arthritis Rheumatol. 2016;68(suppl 10). \n                    http:\/\/acrabstracts.org\/abstract\/comprehensive-aptamer-based-screening-of-1129-proteins-reveals-novel-urinary-biomarkers-of-lupus-nephritis\/\n                    \n                  . Accessed 5 Jan 2018."},{"key":"1498_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13075-016-1120-0","volume":"18","author":"C Landolt-Marticorena","year":"2016","unstructured":"Landolt-Marticorena C, Prokopec SD, Morrison S, Noamani B, Bonilla D, Reich H, et al. A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis. Arthritis Res Ther. 2016;18:218.","journal-title":"Arthritis Res Ther"},{"key":"1498_CR14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.leukres.2008.11.019","volume":"33","author":"D Ribatti","year":"2009","unstructured":"Ribatti D. Endogenous inhibitors of angiogenesis: a historical review. Leuk Res. 2009;33:638\u201344.","journal-title":"Leuk Res"},{"key":"1498_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1191\/096120398678920172","volume":"7","author":"Y Ikeda","year":"1998","unstructured":"Ikeda Y, Fujimoto T, Ameno M, Shiiki H, Dohi K. Relationship between lupus nephritis activity and the serum level of soluble VCAM-1. Lupus. 1998;7:347\u201354.","journal-title":"Lupus"},{"key":"1498_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2249.1994.tb06107.x","volume":"97","author":"PE Spronk","year":"1994","unstructured":"Spronk PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CG. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol. 1994;97:439\u201344.","journal-title":"Clin Exp Immunol"},{"key":"1498_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13075-015-0896-7","volume":"18","author":"MJ Lewis","year":"2016","unstructured":"Lewis MJ, Vyse S, Shields AM, Zou L, Khamashta M, Gordon PA, et al. Improved monitoring of clinical response in systemic lupus erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1. Arthritis Res Ther. 2016;18:5. https:\/\/doi.org 10.1186\/s13075-015-0896-7.","journal-title":"Arthritis Res Ther"},{"key":"1498_CR18","first-page":"403","volume":"20","author":"Y Molad","year":"2002","unstructured":"Molad Y, Miroshnik E, Sulkes J, Pitlik S, Weinberger A, Monselise Y. Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage. Clin Exp Rheumatol. 2002;20:403\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"1498_CR19","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3899\/jrheum.111470","volume":"39","author":"AN Kiani","year":"2012","unstructured":"Kiani AN, Wu T, Fang H, Zhou XJ, Ahn CW, Magder LS, et al. Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis. J Rheumatol. 2012;39:1231\u20137.","journal-title":"J Rheumatol"},{"key":"1498_CR20","doi-asserted-by":"publisher","first-page":"R164","DOI":"10.1186\/ar3912","volume":"14","author":"S Singh","year":"2012","unstructured":"Singh S, Wu T, Xie C, Vanarsa K, Han J, Mahajan T, et al. Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis. Arthritis Res Ther. 2012;14:R164.","journal-title":"Arthritis Res Ther"},{"key":"1498_CR21","doi-asserted-by":"publisher","first-page":"e2657","DOI":"10.1371\/journal.pone.0002657","volume":"3","author":"S Aidoudi","year":"2008","unstructured":"Aidoudi S, Bujakowska K, Kieffer N, Bikfalvi A. The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis. PLoS One. 2008;3:e2657.","journal-title":"PLoS One"},{"key":"1498_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L van Bon","year":"2014","unstructured":"van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, et al. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med. 2014;370:433\u201343.","journal-title":"N Engl J Med"},{"key":"1498_CR23","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"1498_CR24","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa051135","volume":"353","author":"M Petri","year":"2005","unstructured":"Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2550\u20138.","journal-title":"N Engl J Med"},{"key":"1498_CR25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","volume":"142","author":"JP Buyon","year":"2005","unstructured":"Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005;142:953\u201362.","journal-title":"Ann Intern Med"},{"key":"1498_CR26","first-page":"53","volume":"19","author":"M Petri","year":"1992","unstructured":"Petri M, Hellmann D, Hochberg M. Validity and reliability of lupus activity measures in the routine clinic setting. J Rheumatol. 1992;19:53\u20139.","journal-title":"J Rheumatol"},{"key":"1498_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","volume":"79","author":"MS O\u2019Reilly","year":"1994","unstructured":"O\u2019Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315\u201328.","journal-title":"Cell"},{"key":"1498_CR28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/jcb.10762","volume":"91","author":"MR Sharma","year":"2004","unstructured":"Sharma MR, Tuszynski GP, Sharma MC. Angiostatin-induced inhibition of endothelial cell proliferation\/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5. J Cell Biochem. 2004;91:398\u2013409.","journal-title":"J Cell Biochem"},{"key":"1498_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00441-013-1753-0","volume":"355","author":"GK Aulakh","year":"2014","unstructured":"Aulakh GK, Balachandran Y, Liu L, Singh B. Angiostatin inhibits activation and migration of neutrophils. Cell Tissue Res. 2014;355:375\u201396.","journal-title":"Cell Tissue Res"},{"key":"1498_CR30","doi-asserted-by":"publisher","first-page":"F145","DOI":"10.1152\/ajprenal.90430.2008","volume":"296","author":"W Mu","year":"2009","unstructured":"Mu W, Long DA, Ouyang X, Agarwal A, Cruz PE, Roncal CA, et al. Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism. Am J Physiol Renal Physiol. 2009;296:F145\u201352.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1498_CR31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/0006-291X(92)91234-H","volume":"187","author":"R Pigott","year":"1992","unstructured":"Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun. 1992;187:584\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"1498_CR32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/03009740701406460","volume":"36","author":"PA Klimiuk","year":"2007","unstructured":"Klimiuk PA, Fiedorczyk M, Sierakowski S, Chwiecko J. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis. Scand J Rheumatol. 2007;36:345\u201350.","journal-title":"Scand J Rheumatol"},{"key":"1498_CR33","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.jaci.2005.09.035","volume":"116","author":"P Romagnani","year":"2005","unstructured":"Romagnani P, Maggi L, Mazzinghi B, Cosmi L, Lasagni L, Liotta F, et al. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. J Allergy Clin Immunol. 2005;116:1372\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"1498_CR34","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.4049\/jimmunol.174.5.2680","volume":"174","author":"CY Liu","year":"2005","unstructured":"Liu CY, Battaglia M, Lee SH, Sun QH, Aster RH, Visentin GP. Platelet factor 4 differentially modulates CD4\u2009+\u2009CD25+ (regulatory) versus CD4\u2009+\u2009CD25- (nonregulatory) T cells. J Immunol. 2005;174:2680\u20136.","journal-title":"J Immunol"},{"key":"1498_CR35","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1160\/TH10-03-0193","volume":"104","author":"S Aidoudi","year":"2010","unstructured":"Aidoudi S, Bikfalvi A. Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis. Thromb Haemost. 2010;104:941\u20138.","journal-title":"Thromb Haemost"},{"key":"1498_CR36","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1160\/TH03-02-0069","volume":"90","author":"S Pitsilos","year":"2003","unstructured":"Pitsilos S, Hunt J, Mohler ER, Prabhakar AM, Poncz M, Dawicki J, et al. Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost. 2003;90:1112\u201320.","journal-title":"Thromb Haemost"},{"key":"1498_CR37","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/j.1600-6143.2009.02645.x","volume":"9","author":"S Schaub","year":"2009","unstructured":"Schaub S, Nickerson P, Rush D, Mayr M, Hess C, Golian M, et al. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis. Am J Transplant. 2009;9:1347\u201353.","journal-title":"Am J Transplant"},{"key":"1498_CR38","doi-asserted-by":"publisher","first-page":"7166","DOI":"10.4049\/jimmunol.179.10.7166","volume":"179","author":"T Wu","year":"2007","unstructured":"Wu T, Xie C, Wang HW, Zhou XJ, Schwartz N, Calixto S, et al. Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol. 2007;179:7166\u201375.","journal-title":"J Immunol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1498-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-017-1498-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1498-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:55:07Z","timestamp":1589550907000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1498-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1498-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,11]]},"assertion":[{"value":"3 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was approved by the Research and Ethics Committee of Tuen Mun Hospital, Hong Kong (CREC\/848\/10). Informed written consent was obtained from all the participants and the consent forms were held by the first author\u2019s institution.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was obtained from all participants for publication of the scientific data generated from this study. However, data and images from individual patients would not be published as all data presented are the median or mean of the whole study population.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"6"}}